MetaCap

Processa Pharmaceuticals (PCSA) News

NASDAQ: PCSAHealth CareBiotechnology: Pharmaceutical PreparationsUSD

1.56-0.13 (-7.69%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

PCSA news summary

We found 4 recent headlines mentioning Processa Pharmaceuticals (PCSA): 0 in the past week and 4 in the past 30 days, most often from Nasdaq, GlobeNewswire. PCSA is making an outsized move today, down 7.69% at $1.56, which often coincides with company-specific news. Check the latest headlines below for the likely catalyst. The most recent story, "Processa Pharmaceuticals, Inc. Appoints Gregory J. Flesher as Chief Operating Officer and Announces Key Leadership Additions", was published by Nasdaq on Nov 4, 2026.

Headlines link to the original publishers. MetaCap does not republish third-party articles.

Summary generated from market data by MetaCap's automated system. Methodology

Latest Processa Pharmaceuticals headlines

Compare PCSA